Continuing Medical Education For HCPs
Staying updated with the latest advancements in cancer health is essential for healthcare professionals. Our Continuing Medical Education (CME) resources offer in-depth insights into the evolving landscape of oncology. Explore a range of educational materials designed to empower medical professionals with the knowledge needed to offer the best possible care to patients dealing with cancer. Stay informed about the latest treatment approaches, research findings, and innovative therapies.
Sponsored By
Investigation of 2X-121 in Patients With Advanced Ovarian Cancer Selected by the 2X-121 DRP�
This study is to be performed as an open label, multicenter, single arm study of 2X-121 to evaluate anti-tumor efficacy of 2X-121 as single agent therapy in a 28-days cycle in advanced ovarian cancer ...
Condition: Advanced Ovarian Cancer
A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction
The researchers are doing this study to look at the number of complications that occur immediately after prepectoral breast reconstruction when Acellular Dermal Matrix (ADM) is used compared to when A ...
Condition: Breast Cancer
A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma
CO40939 is a Phase Ib, open-label, multicenter, single-arm study designed to evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of cibisatamab in combination with atezolizumab adminis ...
Condition: Colorectal Cancer
Bioinformatics analysis and experimental verification of TIGD1 in non-small cell lung cancer
Introduction: Non-small cell lung cancer (NSCLC) is a prevalent respiratory system tumor. Triggered transposable element derivative 1 (TIGD1) exhibits significant overexpression in various tumor cells
Caring for a child with cancer during COVID-19 pandemic: an assessment of the parents perception and stress level
Background: The emergence of COVID-19 pandemic has led to heightened fear and uncertainty among parents of children with cancer. This study was conducted to evaluate the parental perceptions toward ef
A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer
Background: The epidermal growth factor receptor (EGFR) ex20ins mutation, as a rare subtype of mutation, has gradually attracted attention. Its heterogeneity is high, its prognosis is extremely poor,
Mayo Clinic Minute: What you should know about colorectal cancer
Cancer of the rectum and colon often are referred together as colorectal cancer, but treatments can be different. Dr. David Etzioni ...
Genetic Insights: Family History and the BRCA Gene in Breast Cancer - with Dr Tasha
Family history of breast cancer and the BRCA gene are closely related when considering the risk factors for developing breast ...
Let's Talk About It: Ovarian Cancer - Integrative Medicine
Eugenie Spiguel, a Nurse Practitioner at Memorial Sloan Kettering Cancer Center, discusses integrative medicine and how it can ...